Advertisement

You are subscribed to the Formulary Watch eNews.

AMCP 2015
Twitter Facebook

View Online  |  Share With A Colleague  |  eNewsletter Subscribe

AMCP Review

In our continuing post-conference series from the Academy of Managed Care Pharmacy (AMCP) 27th Annual Meeting & Expo, which was held in San Diego, CA, we highlight the key presentations you may have missed! Read more to access information that will impact managed care pharmacy.

Highlights

A properly designed compounding benefit can help control costs and quality

A properly designed compounding benefit that works with industry providers is more effective at controlling costs and quality than a negative approach that can limit patient care and potentially increase costs. Read more.

Better health, lower costs the result of incorporating pharmacists in the management of complex patients

Incorporating pharmacists into a team approach for care of patients who require specialty pharmacy services can help manage cost and improve medication adherence. Read more.

The benefit of patient-focused MTM services

If the approach to medication therapy management (MTM) is flexible, integration of MTM services into the design of a health plan can impact plan performance and result in a positive return on investment. Read more.

Post-Conference coverage

Check the AMCP section for added content each day, click here for more

April 25, 2015

Advertisement

Related Links

Closed formularies hold the line on costs

Specialty drugs and the role of managed care pharmacy

Pharma Pricing Strategies: Prior authorizations, specialty pharmacies seen as solutions

We welcome your feedback!
Please send your comments to:

Tracey Walker

Content Manager

FormularyWatch

[email protected]

DISCLAIMER:
This information has been independently developed and provided by the editors of Formulary Watch. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logo
UBM  logo

UBM MEDICA